About exenatide unit dose
GLP-1 receptor agonist
Used for
- Improves blood sugar control in adults with type 2 diabetes, alongside diet and exercise.
Usual adult dose
Inject under the skin twice daily within 60 minutes before morning and evening meals. Usually start at 5 micrograms twice daily for one month, then increase to 10 micrograms twice daily if needed.
Common side effects
- Nausea
- Vomiting
- Diarrhea
- Low blood sugar, especially with insulin or sulfonylureas
Important warnings
- Not for type 1 diabetes or diabetic ketoacidosis.
- Pancreatitis has been reported; seek urgent assessment for severe, persistent abdominal pain.
- Avoid in severe kidney impairment or end-stage kidney disease.
- May reduce absorption of medicines taken by mouth; discuss timing with a clinician.
Pregnancy
Use is generally not recommended during pregnancy because safety information is limited; treatment should be reviewed by a clinician.
Breastfeeding
It is unknown whether exenatide passes into breast milk; breastfeeding treatment decisions should be reviewed with a clinician.
Interactions
- Insulin or sulfonylureas can increase low blood sugar risk.
- May affect absorption of oral medicines, especially those requiring rapid absorption.
- Warfarin: monitor blood clotting measures when starting or changing treatment.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.